| Application no. and date | 08105552.7 (espacenet) (Federated) (European Patent Register), 20030122 | | Patent/reg. no. and date | DK/EP 2045241, 20120704 | | Publication date | 20090408 | | Priority no. and date | US 351384 P, 20020124 | | EP pub. no. and date |
EP 2045241 20090408 | | Effective date | | | Applicant/owner | Merck Canada Inc., 16711 Trans-Canada Highway
Kirkland, QC H9H 3L1, CA | | Applicant ref. no. | 11266-4DK | | Inventor | Berthelette, Carl, Merck Frosst Canada Limited
16711 Trans-Canada Highway
Kirkland Québec H9H 3L1, CA,
Lachance, Nicolas, Merck Frosst Canada Limited
1671 Trans-Canada Highway
Kirkland Québec H9H 3L1, CA,
Li, Lianhai, Merck Frosst Canada Limited
16711 Trans-Canada Highway
Kirkland Québec H9H 3L1, CA,
Sturino, Claudio, Merck Frosst Canada Limited
1671 Trans-Canada Highway
Kirkland Québec H9H 3L1, CA,
Wang, Zhaoyin, Merck Frosst Canada Limited
16711 Trans-Canada Highway
Kirkland Québec H9H 3L1, CA | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/403 (2006.01) , A61P 43/00 (2006.01) , C07D 209/80 (2006.01) , C07D 209/88 (2006.01) | | Title | Fluorsubstituerede cycloalkanoindoler og anvendelse deraf som prostaglandin D2-receptorantagonister | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
